Latest News for Mesoblast Stock (OTC:MEOBF)

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.

Cannabis

News

Penny Stocks

Psychedelics

Small Cap

Markets

AVTX

HALO

MEOBF

MNMD

Mind Medicine Inc. (NASDAQ: MNMD), (NEO:MMED), a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO.

MindMed Appoints Schond L. Greenway As CFO

Mesoblast Ltd

In a report released on March 1, David Stanton from Jefferies maintained a Buy rating on Mesoblast Limited (MEOBF – Research Report), with a price ...

Mesoblast Limited (MEOBF) Receives a Buy from Jefferies

Piper Sandler analyst Edward Tenthoff initiated coverage with a Hold rating on Mesoblast (MESO – Research Report) today and set a price target of $...

Mesoblast (MESO) Gets a Hold from Piper Sandler

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aprea Therapeutics (APRE – Research Report), Biogen ...

Analysts Offer Insights on Healthcare Companies: Aprea Therapeutics (APRE), Biogen (BIIB) and Mesoblast Limited (OtherMEOBF)

Mesoblast Limited: Back From The Dead

Mesoblast Limited (AU:MSB) has released an update. Mesoblast Limited has announced the cessation of 80,000 options due to unmet conditions, with th...

Mesoblast Reports Lapse of 80,000 Options

Mesoblast Limited (AU:MSB) has released an update. Mesoblast Limited has announced the issue of 7,106,863 unquoted equity securities, specifically ...

Mesoblast Limited Issues Employee Incentive Options

Mesoblast Limited (AU:MSB) has released an update. In a recent update from Mesoblast Limited, Director Jane C. Bell has increased her indirect hold...

Mesoblast Director Buys Shares On-Market

Mesoblast Limited (AU:MSB) has released an update. Mesoblast Limited announces a change in leadership as Joseph R. Swedish steps down as Chair, wit...

Mesoblast Appoints New Chair Amid Growth Phase

Mesoblast Limited (AU:MSB) has released an update. Mesoblast Limited, a biopharmaceutical company, has reported progress with the FDA on their cell...

Mesoblast Advances FDA Approval Process

Mesoblast Limited (AU:MSB) has released an update. Mesoblast Limited has reported a change in its substantial holding, with Gregory George and G to...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Mesoblast Stock (OTC:MEOBF)

Monday, May 23, 2022